HomeECQ0 • FRA
add
Neurizon Therapeutics Ltd
Previous close
€0.080
Day range
€0.079 - €0.079
Year range
€0.059 - €0.14
Market cap
68.64M AUD
Avg Volume
1.50K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Investor's Business Daily
4 hours ago
Warren Buffett Shockingly Dumps 2 Stocks He Told Everyone To Buy
0.25%
WSJ
28 minutes ago
Stock Market Today: Dow Falls 400 Points; Consumer Confidence Slides — Live
Updates
8.76%
0.87%
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 765.72K | 78.63% |
Operating expense | 4.52M | 266.62% |
Net income | -3.64M | -1,770.23% |
Net profit margin | -475.35 | -947.03% |
Earnings per share | — | — |
EBITDA | -3.75M | -419.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.11M | 85.52% |
Total assets | 15.53M | 78.72% |
Total liabilities | 3.62M | 195.26% |
Total equity | 11.91M | — |
Shares outstanding | 492.31M | — |
Price to book | 3.98 | — |
Return on assets | -60.41% | — |
Return on capital | -78.78% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.64M | -1,770.23% |
Cash from operations | -2.67M | -11,199.42% |
Cash from investing | -1.51M | -1,727.80% |
Cash from financing | 4.38M | 196.16% |
Net change in cash | 199.81K | -85.45% |
Free cash flow | -2.25M | -384.83% |
About
Founded
2000
Website
Employees
52
